Immunai

Immunology based personalized disease treatments

Business Overview

Active
Operating Status
Jan 2019
Founded
70
Employees
B2B
Business Model
Software
Offering Type
Description
Decoding the immune system to improve health.Comprehensively mapping the immune system with single-cell biology and AI to power new therapeutic discoveries, accelerate drug development and improve patient outcomes.Cutting-edge biology coupled with machine-learning to unravel the immune system. We are curating the largest proprietary data-set of multi-omic, immune-centric analyses of peripheral tissues. Our advanced analytics and data-visualization interface allows researchers to comprehensively view and interrogate data, and derive novel conclusions on the underlying mechanisms of disease. With a comprehensive view of the immune system, clinicians are better equipped to personalize and optimize treatment choices for each patient, and maximize positive outcomes. Immunai's mission is to transform immunology by pioneering single-cell technologies coupled with the most cutting-edge AI methods.
Business Stage
Product Development

Founders

Luis Voloch
View Email
Noam Solomon
View Email
Danny Wells
Scientific Founder
View Email
Ansuman Satpathy
Scientific Founder
Dan Littman
Scientific Founder
View Email

Register for Pro to view

Board Members and Advisors

Dan Littman
Scientific Founder
View Email
Jimmie Ye
Advisor
Michael Kalos
Advisor
Rahul Satija
Advisor
Regina Barzilay
Advisor
Kimary Kulig
Advisor
Larry Marton
Advisor
Laurence Nore
Advisor
Michael Aberman
Advisor

Investors

Investor

Investor Type

Series Preference

Series A, Series B
Series A, Series B
Series A, Series B
Seed, Series A, Series B
Seed, Series A, Series B, Series C
Seed, Series A, Series B, Series C, Series D, Series E

Funding Rounds

$80,000,000
Total Funding

2

Funding Rounds
Series A
Last Funding Series

Register for Pro to view

Date Announced

Funding Round

Amount Raised

Investors

$60 M
Register Pro to View
$20 M
Register Pro to View

Exit Events and Acquisitions

Date Announced

Transaction

Consideration

Target

Acquirer

July 2021
Startup Acquisition
Nebion
Register Pro to View
March 2021
Startup Acquisition
Dropprint Genomics
Register Pro to View

AI Technology Stack™

Register Pro to View
AI Team Size
3
AI Technologies
AI Types
Register Pro to View
ML Types
Register Pro to View
AI Tools
Register Pro to View
Coding
Register Pro to View
AI Cloud Provider
Register Pro to View

Patents

Register for Pro to view

Research Publications

Register for Pro to view

More Startups

STATUS
Active
STATUS
Active
FUNDING STAGE
Seed
STATUS
Active
STATUS
Active
STATUS
Active
FUNDING
$50,000,000
FUNDING STAGE
Series B
STATUS
Active
STATUS
Active
FUNDING
$20,000,000
FUNDING STAGE
Seed
STATUS
Active
FUNDING STAGE
Seed
STATUS
Active
STATUS
Active
FUNDING
$354,000,000
FUNDING STAGE
Series C
STATUS
Active
STATUS
Active
FUNDING
$156,700,000
FUNDING STAGE
Series D+
STATUS
Active
FUNDING
$15,500,000
FUNDING STAGE
Series A
STATUS
Active
FUNDING
$700,000
STATUS
Active

Startup Snapshot

Operating Status
Active
AI Team Size
Register Pro to View
Total Funding
$80,000,000
Founded
January 2019
Funding Stage
Series A
Time Since Last Funding Round
7 months

Competitors

Sign up for free

  • Save profiles to your list
  • PDF export of startups and investor profiles
  • Basic search functionality

Fundraising Contact